Health Care [ 9/12 ] | Biotechnology [ 43/73 ]
NASDAQ | Common Stock
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases.
The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010.
IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.
As of August 14, 2025, IGM Biosciences, Inc. operates as a subsidiary of Concentra Biosciences, LLC.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 18, 25 | 1.58 Increased by +300.00% | -0.12 Increased by +1.42 K% |
| May 6, 25 | -0.86 Decreased by -3.61% | -0.45 Decreased by -91.11% |
| Mar 5, 25 | -0.61 Increased by +39.60% | -0.71 Increased by +14.16% |
| Nov 11, 24 | -1.01 Increased by +2.88% | -0.80 Decreased by -26.25% |
| Aug 14, 24 | -0.79 Increased by +44.76% | -0.04 Decreased by -1.88 K% |
| May 8, 24 | -0.83 Increased by +37.59% | -0.83 |
| Mar 7, 24 | -1.01 Increased by +15.13% | -1.03 Increased by +1.94% |
| Nov 13, 23 | -1.04 Increased by +21.21% | -1.21 Increased by +14.05% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 143.62 M Increased by +11.35 K% | 97.58 M Increased by +303.72% | Increased by +67.94% Increased by +101.78% |
| Mar 31, 25 | 499.00 K Increased by +0.40% | -52.89 M Decreased by -6.17% | Decreased by -10.60 K% Decreased by -5.75% |
| Dec 31, 24 | 412.00 K Decreased by -36.71% | -36.65 M Increased by +39.62% | Decreased by -8.89 K% Increased by +4.60% |
| Sep 30, 24 | 516.00 K Increased by +1.38% | -61.43 M Increased by +0.90% | Decreased by -11.91 K% Increased by +2.25% |
| Jun 30, 24 | 1.25 M Increased by +179.91% | -47.90 M Increased by +25.64% | Decreased by -3.82 K% Increased by +73.44% |
| Mar 31, 24 | 497.00 K Decreased by -4.79% | -49.82 M Increased by +16.01% | Decreased by -10.02 K% Increased by +11.78% |
| Dec 31, 23 | 651.00 K Increased by +75.00% | -60.70 M Decreased by -25.93% | Decreased by -9.32 K% Increased by +28.04% |
| Sep 30, 23 | 509.00 K Increased by +53.78% | -61.99 M Decreased by -11.57% | Decreased by -12.18 K% Increased by +27.45% |